Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
L Rochette, C Guenancia, A Gudjoncik… - Trends in …, 2015 - cell.com
Anticancer drugs continue to cause significant reductions in left ventricular ejection fraction
resulting in congestive heart failure. The best-known cardiotoxic agents are anthracyclines …
resulting in congestive heart failure. The best-known cardiotoxic agents are anthracyclines …
The HSP90 molecular chaperone—an enigmatic ATPase
LH Pearl - Biopolymers, 2016 - Wiley Online Library
The HSP90 molecular chaperone is involved in the activation and cellular stabilization of a
range of 'client'proteins, of which oncogenic protein kinases and nuclear steroid hormone …
range of 'client'proteins, of which oncogenic protein kinases and nuclear steroid hormone …
Hsp90 mediates membrane deformation and exosome release
E Lauwers, YC Wang, R Gallardo, R Van der Kant… - Molecular cell, 2018 - cell.com
Hsp90 is an essential chaperone that guards proteome integrity and amounts to 2% of
cellular protein. We now find that Hsp90 also has the ability to directly interact with and …
cellular protein. We now find that Hsp90 also has the ability to directly interact with and …
Targeting mutant p53 for cancer treatment: moving closer to clinical use?
MJ Duffy, M Tang, S Rajaram, S O'Grady, J Crown - Cancers, 2022 - mdpi.com
Simple Summary Cancer is largely caused by genetic alterations such as mutations in a
group of genes known as cancer driver genes. Many of the key advances in cancer …
group of genes known as cancer driver genes. Many of the key advances in cancer …
Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside
M Aruanno, E Glampedakis… - Antimicrobial agents and …, 2019 - Am Soc Microbiol
ABSTRACT Echinocandins (caspofungin, micafungin, anidulafungin), targeting β-1, 3-
glucan synthesis of the cell wall, represent one of the three currently available antifungal …
glucan synthesis of the cell wall, represent one of the three currently available antifungal …
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes
RM Mbofung, JA McKenzie, S Malu, M Zhang… - Nature …, 2017 - nature.com
T-cell-based immunotherapies are promising treatments for cancer patients. Although
durable responses can be achieved in some patients, many patients fail to respond to these …
durable responses can be achieved in some patients, many patients fail to respond to these …
[HTML][HTML] Combination therapies with HSP90 inhibitors against colorectal cancer
Oncogene stability and homeostasis mediated by the HSP90 chaperone is a crucial
protection trait of cancer cells. Therefore, HSP90 represents an attractive therapeutic target …
protection trait of cancer cells. Therefore, HSP90 represents an attractive therapeutic target …
First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphoma
VC Gibouin, M Durand, C Boudesco, F Hermetet… - Leukemia, 2024 - nature.com
Activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL) is driven by aberrant
activation of the B-cell receptor (BCR) and the TLR/MyD88 signaling pathways. The heat …
activation of the B-cell receptor (BCR) and the TLR/MyD88 signaling pathways. The heat …
Biological actions of the Hsp90-binding immunophilins FKBP51 and FKBP52
NR Zgajnar, SA De Leo, CM Lotufo, AG Erlejman… - Biomolecules, 2019 - mdpi.com
Immunophilins are a family of proteins whose signature domain is the peptidylprolyl-
isomerase domain. High molecular weight immunophilins are characterized by the …
isomerase domain. High molecular weight immunophilins are characterized by the …
Adapting to stress—chaperome networks in cancer
In this Opinion article, we aim to address how cells adapt to stress and the repercussions
chronic stress has on cellular function. We consider acute and chronic stress-induced …
chronic stress has on cellular function. We consider acute and chronic stress-induced …